BIOREGENX, INC. (BRGX) Operating cash flow 2021–2025
BIOREGENX, INC. (BRGX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$38,972FY2025 · since FY2021: -$119,517 → $38,972
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $38,972 | +112.0% |
| FY2024 | -$324,148 | +78.6% |
| FY2023 | -$1.5M | -2243.4% |
| FY2022 | -$64,652 | +45.9% |
| FY2021 | -$119,517 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BRGX financial trends
BRGX RevenueBRGX Net incomeBRGX Net marginBRGX Gross profitBRGX Gross marginBRGX Operating incomeBRGX Operating marginBRGX Free cash flowBRGX Capital expendituresBRGX Return on equityBRGX Stock buybacksBRGX Dividends paidBRGX Total assetsBRGX Total liabilitiesBRGX Shareholders’ equityBRGX overview →